About Embecta Corp. 
Embecta Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 71 Schemes (55.3%)
Foreign Institutions
Held by 145 Foreign Institutions (7.92%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
296 Million
(Quarterly Results - Jun 2025)
Net Profit:
46 Million
Pharmaceuticals & Biotechnology
USD 857 Million (Small Cap)
6.00
NA
3.05%
-1.86
-999,999.00%
-1.28






